SpineGuard and XinRong Medical Group Sign Exclusive Distribution Agreement For PediGuard® in China

China Market Report: China On The Way To Become The Largest Telehealth Market
June 27, 2017
China and Other Emerging Medtech Markets Ready for Global Stage
July 5, 2017

SpineGuard and XinRong Medical Group Sign Exclusive Distribution Agreement For PediGuard® in China

June 21, 2017 12:00 PM Eastern Daylight Time

 

SpineGuard an innovative company that develops and markets disposable medical devices designed to make spine surgery safer, announced today an exclusive distribution agreement with XinRong Medical Group for PediGuard® in China, Hong Kong and Macau.

China’s spine market has become the world’s second-largest market after the USA and is expected to be worth over $1 billion by 20191, driven by an aging population, increasing disease prevalence and treatment rates, along with growing affordability.

We are excited about this agreement and believe that XinRong Medical Group has all of the right attributes to successfully introduce PediGuard® in China, a market with great commercial potential. The number of spine fusions continues to grow rapidly across the country creating a substantial need for an easy-to-use smart device to secure the placement of pedicle screws consistently. Since its clearance by CFDA, numerous Chinese orthopedists and neurosurgeons have expressed a strong interest for our DSG™ technology. We now very much look forward to seeing them adopt it in their spine surgery practice,” said Pierre Jérôme, CEO and co-founder of SpineGuard.

China Med Device, LLC, specializing in providing turn-key solutions for medtech companies entry into China, brings you up-to-date information on CFDA. If you have any feedback, please email us at info@ChinaMedDevice.com or visit us at www.ChinaMedDevice.com.